Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lek pharmaceuticals d.d. - slovenia - mometasonum - spray naz.,susp. - 50micrograme/doza - decongestionante si alte medicamente nazale de uz topic corticosteroidiene

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

organon heist bv - belgia - mometasonum - pulb. inhal. - 200µg/doza - alte med. pt.trat. bolilor obstructive ale c.r, inhalatorii glucocorticoizi

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

organon heist bv - belgia - mometasonum - pulb. inhal. - 400µg/doza - alte med. pt.trat. bolilor obstructive ale c.r, inhalatorii glucocorticoizi

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

organon heist bv - belgia - mometasonum - crema - 1mg/g - corticosteroizi simpli corticosteroizi cu potenta mare (grup iii)

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

organon heist bv - belgia - mometasonum - unguent - 1mg/g - corticosteroizi simpli corticosteroizi cu potenta mare (grup iii)

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

schering-plough labo n.v. - belgia - mometasonum - spray nazal susp. - 50micrograme/doza - decongestionante si alte medicamente nazale de uz topic corticosteroidiene

Europese Unie - Roemeens - EMA (European Medicines Agency)

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Europese Unie - Roemeens - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol acetate, mometasone furoate - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Europese Unie - Roemeens - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - maintenance treatment of asthma in adults whose disease is not adequately controlled.

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

organon heist bv - belgia - mometasonum - spray naz.,susp. - 50micrograme/doza - decongestionante si alte medicamente nazale de uz topic corticosteroidiene